Welcome to our dedicated page for QT IMAGING HOLDINGS SEC filings (Ticker: QTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QT Imaging Holdings, Inc. (QTI) files SEC reports as a Nasdaq-listed medical device company focused on body imaging systems that use low-frequency sound waves. Its filings are useful for following how the company describes the commercialization, regulation and financing of its Breast Acoustic CT imaging platform.
Quarterly reports on Form 10-Q provide financial statements, accounting notes and management disclosures. For QTI, these reports have included items tied to breast scanning system placements, revenue expectations used in earnout liability valuation, warrants, reverse stock split adjustments and share information. Annual reports on Form 10-K, when filed, provide broader business, risk and financial disclosures.
Current reports on Form 8-K are especially relevant for QTI because they document material events between periodic reports. Recent 8-K categories include earnings releases, shareholder communications, financing agreements, stockholder meeting results, executive compensation actions and equity award grants. These filings help show how QT Imaging communicates operational updates, governance actions and capital markets activity.
The company's proxy statements describe matters submitted to stockholders, including director elections, auditor ratification and equity incentive plan proposals. For a medical device issuer such as QTI, SEC filings help investors evaluate the link between product commercialization, regulatory disclosures, governance decisions and the capital structure supporting the company's imaging technology business.
QT Imaging Holdings, Inc. filed an amended current report to add the full agreements related to its Chief Financial Officer’s resignation. On August 22, 2025, Anastas Budagov informed the board he would resign as CFO effective August 29, 2025. He was not contractually entitled to severance, but the parties entered into a Separation and Release Agreement under which he will receive $150,000 in lieu of severance in exchange for a release of all claims against the company.
The company and Mr. Budagov also signed a Consulting Agreement. From August 29, 2025 through November 15, 2025, he will serve as an advisor at an hourly rate of $180, payable monthly, with an aggregate cap of $20,000 that the company can change with prior written notice. He is generally not expected to work more than ten hours per week unless adjusted. His outstanding stock options will continue to vest under their existing terms during the consulting period.
QT Imaging Holdings, Inc. reported that its Board of Directors approved higher compensation for Chief Executive Officer Dr. Raluca Dinu. Effective September 1, 2025, her base salary increases from $470,000 to $550,000 per year. Her target annual bonus also rises from 65% of salary to 75% of salary, reflecting updated terms of her executive pay package.
Alta Partners LLC reported beneficial ownership of 1,698,704 shares of QT Imaging Holdings, Inc. common stock, representing 5.58% of the class. The filing states these shares are "shares issuable upon exercise of warrants," and Alta Partners reports sole voting and dispositive power over all 1,698,704 shares. The statement affirms the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing is submitted on Schedule 13G and signed by Steven Cohen as Managing Member of Alta Partners LLC.
QT Imaging Holdings’ Second Amended and Restated Certificate of Incorporation, effective March 4, 2024, grants broad indemnification to current and former directors, officers, employees and agents to the fullest extent permitted by law. The Charter and cited Delaware law (Section 145 of the DGCL) allow the company to pay or advance expenses, including attorneys’ fees, judgments, fines, ERISA excise taxes and settlement amounts, for persons involved in threatened, pending or completed proceedings arising from service to the company or at its request for other entities. The DGCL also expressly permits insurance to cover such liabilities. The filing restates that indemnification rights are nonexclusive and confirms advancement of defense expenses subject to applicable law.
QT Imaging Holdings, Inc. disclosed the appointment of Michael Jennings as Chief Financial Officer with a CFO employment agreement that provides, if terminated without a Change of Control and upon an effective release of claims, nine months of his then-current base salary paid monthly, continuation of company-paid health coverage for up to nine months (or until he begins comparable full-time coverage), and immediate vesting of equity awards through the next scheduled vesting date. Mr. Jennings, age 58, is a CPA with senior finance experience at UpHealth and eHealth and has led finance, SEC reporting, and large system implementations.
The company also announced a Warrant Repurchase Agreement providing $5.0 million in new funding to repurchase and cancel Yorkville warrants, as disclosed in press releases attached as exhibits.
QT Imaging Holdings, Inc. entered into a three-year exclusive distribution agreement with Gulf Medical Co. covering sales of its QT Breast Acoustic CT Scanners and QTI Cloud Platform SaaS subscriptions in Saudi Arabia. The deal runs from August 21, 2025 through August 21, 2028 and can be extended for one year if Gulf Medical meets defined minimum purchase and revenue requirements. If these minimums are not met, QT Imaging may either terminate exclusivity while continuing non-exclusive supply or terminate the agreement. Gulf Medical is responsible for local regulatory approvals, shipping-related costs, and taxes in Saudi Arabia, while QT Imaging provides training, professional services, warranty coverage of at least one year and up to five years, and retains all intellectual property rights.
QT Imaging Holdings, Inc. reported the results of its 2025 Annual Meeting of Stockholders held on August 19, 2025. Stockholders representing 20,846,542 of the 28,710,144 shares of common stock entitled to vote were present, establishing a quorum. Two Class I directors, Daniel Dickson and James Greene, were elected, receiving 17,768,717 and 17,798,921 votes “for,” respectively. Stockholders also ratified BPM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, with 20,677,932 votes “for.” In addition, stockholders approved an amendment to the Second Amended and Restated Certificate of Incorporation to authorize a reverse stock split at a ratio between 2:1 and 20:1, to be fixed by the Board, with 19,621,693 votes “for.”
Zeev Weiner, a director of QT Imaging Holdings, Inc. (QTI/QTIH), was granted 25,000 stock options on 08/11/2025 with an exercise price of $1.90. The option award is reported as a direct holding and the filing shows 25,000 derivative securities beneficially owned following the transaction.
The grant vests one-third on August 15, 2026, with the remaining two-thirds vesting in eight equal quarterly installments on each November 15, February 15, May 15 and August 15, resulting in full vesting on August 15, 2028, subject to continued service. The Form 4 is signed by Zeev Weiner on 08/13/2025 and lists an expiration date of 08/11/2035 for the option term as reported.
QT Imaging Holdings, Inc. director Taylor Ross was granted 25,000 stock options with an exercise price of $1.90, reported as a Section 16 Form 4 filing. The options were granted on 08/11/2025 and are exercisable for common stock.
Vesting is time-based: one-third vests on August 15, 2026, and the remaining two-thirds vest in eight equal quarterly installments on each November 15, February 15, May 15 and August 15, resulting in full vesting on August 15, 2028, subject to continued service. The report identifies the award as a direct beneficial ownership of 25,000 options.
QT Imaging Holdings reported an insider grant of 25,000 stock options to John C. Klock Jr., a director and 10% owner. The options were granted on 08/11/2025 with an exercise price of $1.90 and cover 25,000 underlying shares of common stock. The filing indicates the options are held directly and shows an expiration date of 08/11/2035.
The grant vests over time: one-third vests on August 15, 2026, and the remaining two-thirds vest in eight equal quarterly installments each Nov 15, Feb 15, May 15, and Aug 15, becoming fully vested on August 15, 2028, subject to continued service. The Form 4 was signed by Mr. Klock on 08/13/2025.